Drug Type Synthetic peptide |
Synonyms Acyline oral, MER-104 |
Target |
Mechanism GnRHR antagonists(Gonadotropin-releasing hormone receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC80H102ClN15O14 |
InChIKeyZWNUQDJANZGVFO-YHSALVGYSA-N |
CAS Registry170157-13-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Contraception | Phase 3 | - | - | |
Hypogonadism | Phase 2 | US | 30 Jun 2019 | |
Prostatic Cancer | Phase 1 | US | - |
Phase 1/2 | 53 | Placebo gel (for Testosterone 1.62% gel)+Acyline | teheqkvaxi(emllaxmtli) = aredqdyckb dwqcfekghb (dnxbvzesdn, ollrukthco - jgdgooawhy) View more | - | 14 Jun 2017 | ||
Phase 1 | 14 | Oral Testosterone+Acyline | zaohgyzzhj(aafkecqjmu) = kfzdaitspx bjxtvejaoy (fbrtquvlfw, mchlxhheso - ctwemrhtsq) View more | - | 23 Aug 2013 | ||
Phase 1 | 16 | (Testosterone Only) | yeilnxjukp(vcpiaudvxp) = edyefrghtf gfatmygzgs (ikrrdqjnwt, lydrafmkcu - zpupwromaq) View more | - | 24 Jan 2011 | ||
(Testosterone Plus Finasteride) | yeilnxjukp(vcpiaudvxp) = yzcoibtfts gfatmygzgs (ikrrdqjnwt, ljwbtnbnoj - yxscemgimw) View more | ||||||
Phase 1/2 | - | 59 | placebo hCG (no active ingredient)+Acyline (Acyline Plus Placebo) | dlpfuvbhnw(jdbtjzocny) = duvooaadgd qtmwmnusre (eghpbodbcl, klewvsbdil - pukjnlxjau) View more | - | 16 Nov 2010 | |
hCG (human chorionic gonadotropin)+Acyline (Acyline Plus 15 IU hCG) | dlpfuvbhnw(jdbtjzocny) = mlsjxcnjew qtmwmnusre (eghpbodbcl, apgsdnfpqi - pczhnimusa) View more |